a potential novel hemophilia treatment: an in vitro study of eptacog beta and emicizumab
Published 3 years ago • 99 plays • Length 4:57Download video MP4
Download video MP3
Similar videos
-
1:23
the present and future of hemophilia a treatment
-
4:43
novel treatments being explored for patients with hemophilia: highlights from isth 2024
-
4:01
emicizumab for hemophilia a: interim analysis of the real-world emiil study
-
3:00
eptacog beta efficacy in children and adolescents with hemophilia a or b with inhibitors
-
2:08
an overview of ongoing clinical trials for the treatment of hemophilia
-
1:34
understanding hemophilia
-
17:48
life with hemophilia after gene therapy (from the peruvian amazon) | wfh2022 presentation
-
11:15
skylar: hemophilia treatment
-
1:18
exigency sub-study: supporting patients with hemophilia when gene therapy is not an option
-
1:23
the safety and efficacy of eptacog beta in patients with hemophilia
-
1:08
the current landscape of hemophilia treatment: an update from ash 2023
-
1:58
how hemophilia care has changed over the years
-
1:17
emerging strategies to support patients with hemophilia a
-
3:01
novel promising agents and clinical trials in amyloidosis
-
1:56
a novel hemophilia a therapy
-
1:33
novel dual-targeting cd19/22 car-t therapy in relapsed all
-
0:54
the potential of daratumumab alone or with cybord in patients with stage iv al amyloidosis
-
2:25
analyzing aml: novel therapies in review
-
5:04
novel therapies and unique delivery methods to improve treatment for bleeding crises, leukemia
-
2:10
treating hemophilia a
-
2:12
improving outcomes in hemophilia a